These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 6455809)

  • 21. Lymphocyte activation during allograft rejection.
    Hersh EM; Butler WT; Rossen RD; Morgen RO; Suki W
    Transplant Proc; 1971 Mar; 3(1):457-60. PubMed ID: 4937918
    [No Abstract]   [Full Text] [Related]  

  • 22. Development of specific nonreactivity in human cadaveric renal allograft recipients.
    Sengar DP; Rashid A; Harris JE
    Tissue Antigens; 1976 May; 7(5):281-90. PubMed ID: 132717
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunologic follow-up renal allograft recipients.
    Hamburger J
    Transplant Proc; 1972 Dec; 4(4):669-71. PubMed ID: 4264871
    [No Abstract]   [Full Text] [Related]  

  • 24. FK506 inhibits human lymphocyte migration and the production of lymphocyte chemotactic factors in liver allograft recipients.
    Adams DH; Liu Q
    Hepatology; 1996 Jun; 23(6):1476-83. PubMed ID: 8675167
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cimetidine prophylaxis after renal transplantation.
    van Roermund HP; Tiggeler RG; Berden JH; van Lier HJ; Koene RA
    Clin Nephrol; 1982 Jul; 18(1):39-42. PubMed ID: 6749361
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulation of T-cell-mediated cytotoxic allograft response in human transplant recipients.
    Thomas J; Thomas F; Edwards E; Hoffman S; Lee HM
    Transplant Proc; 1981 Sep; 13(3):1594-8. PubMed ID: 6458130
    [No Abstract]   [Full Text] [Related]  

  • 27. Prognostic significance of mixed lymphocyte culture reactivity in renal transplantation.
    Beierle MJ; Schmidtke JR; Ferguson RM; Simmons RL; Najarian JS
    Transplant Proc; 1978 Jun; 10(2):451-3. PubMed ID: 150080
    [No Abstract]   [Full Text] [Related]  

  • 28. Monotherapy with LF 15-0195, an analogue of 15-deoxyspergualin, significantly prolongs renal allograft survival in monkeys.
    Yang H; Chen G; Kanai N; Shum J; Garcia B; Huang X; Min W; Luo Y; Dutartre P; Zhong R
    Transplantation; 2003 Apr; 75(8):1166-71. PubMed ID: 12717197
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Suppressor cells in kidney allograft tolerance.
    Charpentier B; Lang P; Martin B; Fries D
    Proc Eur Dial Transplant Assoc; 1981; 18():486-90. PubMed ID: 6460248
    [No Abstract]   [Full Text] [Related]  

  • 30. Correlation between the allogeneic proliferative response and the outcome of renal transplantation.
    Pouteil-Noble C; Betuel H; Freidel AC; Dubernard JM; Touraine JL
    Transplant Proc; 1987 Oct; 19(5):3637-9. PubMed ID: 2960042
    [No Abstract]   [Full Text] [Related]  

  • 31. Patterns of immune response in well tolerated renal grafts.
    Renna E; Pelle M; Nesci C; Alfani D; Cortesini R
    Transplant Proc; 1978 Sep; 10(3):595-8. PubMed ID: 152493
    [No Abstract]   [Full Text] [Related]  

  • 32. Cimetidine and renal-allograft rejection.
    Doherty CC; McGeown MG
    Lancet; 1978 May; 1(8072):1048. PubMed ID: 76969
    [No Abstract]   [Full Text] [Related]  

  • 33. Rejection of human islets and human HLA-A2.1 transgenic mouse islets by alloreactive human lymphocytes in immunodeficient NOD-scid and NOD-Rag1(null)Prf1(null) mice.
    Banuelos SJ; Shultz LD; Greiner DL; Burzenski LM; Gott B; Lyons BL; Rossini AA; Appel MC
    Clin Immunol; 2004 Sep; 112(3):273-83. PubMed ID: 15308121
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Spontaneous proliferative response in patients with chronic renal allograft insufficiency due to chronic rejection].
    Savin M; Ramić Z; Mostarica-StojkovićM ; Djukanović Lj
    Srp Arh Celok Lek; 1994; 122(5-6):142-5. PubMed ID: 17977411
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cimetidine and renal-allograft rejection.
    Rudge CJ; Jones RH; Bewick M; Weston MJ; Parsons V
    Lancet; 1978 May; 1(8074):1154. PubMed ID: 77444
    [No Abstract]   [Full Text] [Related]  

  • 36. Pretransplant platelet transfusions: their effects on renal allograft outcome and mixed lymphocyte culture reactivity.
    Cahen R; Friedel AC; Betuel H; Adeleine P; Robert F; Trolliet P; Francois B
    Transplantation; 1993 Jun; 55(6):1428-31. PubMed ID: 8516830
    [No Abstract]   [Full Text] [Related]  

  • 37. Cimetidine and renal-allograft rejection.
    Charpentier B; Fries D
    Lancet; 1978 Jun; 1(8076):1265. PubMed ID: 78030
    [No Abstract]   [Full Text] [Related]  

  • 38. Interleukin 2 receptor expression in renal biopsies and the diagnosis of acute allograft rejection.
    Mathan A; Kuruvilla S; Abraham G
    Indian J Pathol Microbiol; 2006 Jan; 49(1):12-6. PubMed ID: 16625964
    [TBL] [Abstract][Full Text] [Related]  

  • 39. T cells mediating early acute kidney allograft rejection in the rat are different from those responsible for chronic rejection.
    Braun MY; McCormack A; Webb G; Batchelor JR
    Transplant Proc; 1993 Feb; 25(1 Pt 2):863-4. PubMed ID: 8442250
    [No Abstract]   [Full Text] [Related]  

  • 40. Steroid withdrawal, rejection and the mixed lymphocyte reaction in children after renal transplantation.
    Ingulli E; Sharma V; Singh A; Suthanthiran M; Tejani A
    Kidney Int Suppl; 1993 Oct; 43():S36-9. PubMed ID: 8246367
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.